Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL

European Journal of Cancer

Volumn 46, Issue 13, 2010, Pages 2494-2505

  Kutuk, Ozgur ^a   Temel, Sehime Gulsun ^b   Tolunay, Sahsine ^b   Basaga, Huveyda ^a  

^a SABANCI UNIVERSITY   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Aven; Bcl xL; Breast cancer; DNA damage

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; [5 (2,4 DICHLOROBENZOYL) 2 HYDROXYPHENYL]ACETIC ACID; APOPTOSIS INHIBITOR; APOPTOSIS REGULATORY PROTEIN; CISPLATIN; NUCLEAR PROTEIN; PROTEIN AVEN; PROTEIN BCL XL; PSG5 HEMAGGLUTININ AVEN VECTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; EXPRESSION VECTOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RNA INTERFERENCE; TISSUE MICROARRAY; ULTRAVIOLET IRRADIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-X PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA DAMAGE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MEMBRANE PROTEINS; MICE; MICROARRAY ANALYSIS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING;

EID: 77955922449     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.06.011     Document Type: Article

References (51)

1. W.P. Roos, and B. Kaina DNA damage-induced cell death by apoptosis Trends Mol Med 12 2006 440 450
2. C.J. Norbury, and B. Zhivotovsky DNA damage-induced apoptosis Oncogene 23 2004 2797 2808
3. C.H. Westphal, S. Rowan, and C. Schmaltz Atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity Nat Genet 16 1997 397 401
4. A.M. Cheung, A. Elia, and M.S. Tsao Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice Cancer Res 64 2004 1959 1965
5. S. Boehrer, L. Ades, and N. Tajeddine Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome Oncogene 28 2009 2205 2218
6. A. Bedi, J.P. Barber, and G.C. Bedi BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents Blood 86 1995 1148 1158
7. D.A. Gewirtz Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage Breast Cancer Res Treat 62 2000 223 235
8. T.M. Runger, S. Emmert, and D. Schadendorf Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide J Invest Dermatol 114 2000 34 39
9. P.S. Hodkinson, T. Elliott, and W.S. Wong ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase Cell Death Differ 13 2006 1776 1788
10. P.G. Ekert, A.M. Jabbour, and A. Manoharan Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma Blood 108 2006 1461 1468
11. J.K. Brunelle, E.H. Shroff, and H. Perlman Loss of Mcl-1 protein and inhibition of electron transport chain together induce anoxic cell death Mol Cell Biol 27 2007 1222 1235
12. G.Q. Wang, B.R. Gastman, and E. Wieckowski A role for mitochondrial Bak in apoptotic response to anticancer drugs J Biol Chem 276 2001 34307 34317
13. A. Mandic, K. Viktorsson, and M. Molin Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner Mol Cell Biol 21 2001 3684 3691
14. T.R. Dunkern, G. Fritz, and B. Kaina Ultraviolet light-induced DNA damage triggers apoptosis in nucleotide excision repair-deficient cells via Bcl-2 decline and caspase-3/-8 activation Oncogene 20 2001 6026 6038
15. H. Zou, Y. Li, X. Liu, and X. Wang An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9 J Biol Chem 274 1999 11549 11556
16. M. Certo, V. Del Gaizo Moore, and M. Nishino Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members Cancer Cell 9 2006 351 365
17. A. Letai, M.C. Bassik, and L.D. Walensky Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics Cancer Cell 2 2002 183 192
18. L. Chen, S.N. Willis, and A. Wei Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function Mol Cell 17 2005 393 403
19. S.N. Willis, L. Chen, and G. Dewson Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins Genes Dev 19 2005 1294 1305
20. T.M. Kohl, C. Hellinger, and F. Ahmed BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts Leukemia 21 2007 1763 1772
21. J. Kuroda, S. Kimura, and M. Andreeff ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms Br J Haematol 140 2008 181 190
22. O. Kutuk, and A. Letai Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737 Cancer Res 68 2008 7985 7994
23. Q. Ding, X. He, and W. Xia Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer Cancer Res 67 2007 4564 4571
24. T.A. Buchholz, D.W. Davis, and D.J. McConkey Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy Cancer J 9 2003 33 41
25. L.Y. Bourguignon, W. Xia, and G. Wong Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells J Biol Chem 284 2009 2657 2671
26. O.I. Olopade, M.O. Adeyanju, and A.R. Safa Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases Cancer J Sci Am 3 1997 230 237
27. S.A. Amundson, T.G. Myers, and D. Scudiero An informatics approach identifying markers of chemosensitivity in human cancer cell lines Cancer Res 60 2000 6101 6110
28. B.N. Chau, E.H. Cheng, D.A. Kerr, and J.M. Hardwick Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1 Mol Cell 6 2000 31 40
29. J.Y. Guo, A. Yamada, and T. Kajino Aven-dependent activation of ATM following DNA damage Curr Biol 18 2008 933 942
30. M. Hagg, K. Biven, and T. Ueno A novel high-through-put assay for screening of pro-apoptotic drugs Invest New Drugs 20 2002 253 259
31. J.I. Leu, P. Dumont, M. Hafey, M.E. Murphy, and D.L. George Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex Nat Cell Biol 6 2004 443 450
32. T. Panaretakis, K. Pokrovskaja, M.C. Shoshan, and D. Grander Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin J Biol Chem 277 2002 44317 44326
33. W. Remmele, and H.E. Stegner Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 8 1987 138 140
34. B. Figueroa Jr., S. Chen, G.A. Oyler, J.M. Hardwick, and M.J. Betenbaugh Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions Biotechnol Bioeng 85 2004 589 600
35. A.B. Scoltock, G. Heimlich, and J.A. Cidlowski Glucocorticoids inhibit the apoptotic actions of UV-C but not Fas ligand in hepatoma cells: direct evidence for a critical role of Bcl-xL Cell Death Differ 14 2007 840 850
36. K. Park, and J.H. Lee Bcl-XL protein is markedly decreased in UVB-irradiated basal cell carcinoma cell lines through proteasome-mediated degradation Oncol Rep 21 2009 689 692
37. Y. Nakagawa, S. Okada, and M. Hatano Downregulation of bcl-xL is relevant to UV-induced apoptosis in fibroblasts J Biochem Mol Biol 35 2002 452 458
38. P. Russo, A. Catassi, and D. Malacarne Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells Cancer 103 2005 1503 1518
39. M.T. Tomicic, M. Christmann, and B. Kaina Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3 mediated Bid cleavage J Pharmacol Exp Ther 332 2010 316 325
40. Y. Takeba, T. Kumai, and N. Matsumoto Irinotecan activates p53 with its active metabolite, resulting in human hepatocellular carcinoma apoptosis J Pharmacol Sci 104 2007 232 242
41. M. Villedieu, M.H. Louis, and S. Dutoit Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells Gynecol Oncol 105 2007 31 44
42. L.F. Qin, and I.O. Ng Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells Cancer Lett 175 2002 27 38
43. M. Jiang, Q. Wei, and J. Wang Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis Oncogene 25 2006 4056 4066
44. S. Paydas, K. Tanriverdi, and S. Yavuz Survivin and aven: two distinct antiapoptotic signals in acute leukemias Ann Oncol 14 2003 1045 1050
45. J. Choi, Y.K. Hwang, and K.W. Sung Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia Leuk Res 30 2006 1019 1025
46. C. Huiping, J.T. Johannsdottir, and A. Arason Replication error in human breast cancer: comparison with clinical variables and family history of cancer Oncol Rep 6 1999 117 122
47. C. Huiping, J.R. Sigurgeirsdottir, and J.G. Jonasson Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer Br J Cancer 81 1999 1103 1110
48. A. Broeks, J.H. Urbanus, and A.N. Floore ATM-heterozygous germline mutations contribute to breast cancer-susceptibility Am J Hum Genet 66 2000 494 500
49. Q.N. Vo, W.J. Kim, and L. Cvitanovic The ATM gene is a target for epigenetic silencing in locally advanced breast cancer Oncogene 23 2004 9432 9437
50. R. Kairouz, R.A. Clarke, and P.J. Marr ATM protein synthesis patterns in sporadic breast cancer Mol Pathol 52 1999 252 256
51. S. Angele, I. Treilleux, and P. Taniere Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas Clin Cancer Res 6 2000 3536 3544